Food Standards Australia New Zealand (FSANZ) has approved Chr. Hansen’s 2’-FL human milk oligosaccharide for infant formula in Australian and New Zealand. 2’-FL HMO is the most abundant and most studied human oligosaccharide in breast milk, used in infant formula around the world since 2016.
“As one of the leading suppliers of HMOs, we are pleased to have our 2’-FL HMO ingredient officially approved by national authorities in Australia and New Zealand. In these attractive markets, we can now support our customers in supplying leading infant formula products that are closer to breast milk,” said Jesper Sig Mathiasen, Senior Vice President of Chr. Hansen HMO.
HMO 2’-FL is not only the most studied HMO; it is also the most abundant, making up 20-30% of the total HMO composition in breast milk. It was discovered in 1954 and was the first HMO to be commercially produced and recognised as safe by the North American and European food safety authorities, FDA and EFSA.
HMOs are approved as an ingredient for infant formula in many global markets, now including Chr. Hansen 2’-FL for Australia and New Zealand.
Dr. Katja Parschat, Head of Research & Development at Chr. Hansen HMO said, “Breastfeeding is the best way to ensure infant health and recommended by WHO. At Chr. Hansen, we further aim to support the healthy development of infants that cannot be breastfed by providing HMOs as an ingredient for infant formula.”
Dr Parschat highlighted that latest research showed that HMOs contribute to health benefits, such as supporting the immune system and healthy brain development. Also, HMOs are indicated to support gut maturation and resilience, as well as promotion of a balanced gut microbiome.
Next to 2’-FL, Chr. Hansen also offers a 5 HMO Mix that is composed to reflect the natural concentrations of HMOs in breast milk. It contains HMOs of each structural group (fucosylated HMOs, neutral, non-fucosylated and sialylated HMOs) by including 2’-FL, 3’FL, LNT, 6’-SL and 3’-SL HMOs.
Despite the innovations at Chr. Hansen, the company supports WHO recommendation of breastfeeding exclusively for the first 6 months followed by continued breastfeeding together with complementary foods.
For more information, click on:
Chr Hansen Singapore Pte Ltd
